Insigneo Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Insigneo Advisory Services's XBI Position: Q1 2026 in Review
Insigneo Advisory Services opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 2,108 shares worth $269K. The stake represents 0.02% of the portfolio and ranks #541 among its holdings. This is a return to the name: Insigneo Advisory Services previously reported a position in XBI as recently as Q1 2025.
Insigneo Advisory Services first reported a position in XBI in Q4 2022 and has held it in 9 quarters since. The position peaked at $552K in Q1 2024. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Insigneo Advisory Services held 2,108 shares of State Street SPDR S&P Biotech ETF worth $269K as of Q1 2026.
- State Street SPDR S&P Biotech ETF was a new Insigneo Advisory Services position in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.02% of Insigneo Advisory Services's portfolio in Q1 2026, its #541 holding.
- Insigneo Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 9 quarters since.
- Insigneo Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $552K in Q1 2024.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Insigneo Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.